Problems with the medicalization of marijuana

JAMA

Volumn 311, Issue 23, 2014, Pages 2377-2378

  Wilkinson, Samuel T ^a   D'Souza, Deepak Cyril ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University School of Medicine   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL CANNABIS; TETRAHYDROCANNABINOL;

ALZHEIMER DISEASE; CACHEXIA; CANNABIS SMOKING; CHEMOTHERAPY INDUCED EMESIS; CROHN DISEASE; DRUG CONTAMINATION; DRUG CONTROL; DRUG EFFICACY; DRUG INDICATION; GLAUCOMA; HUMAN; LONG TERM EXPOSURE; MEDICALIZATION; NEUROPATHIC PAIN; NOTE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SPASTICITY;

DRUG APPROVAL; EVIDENCE-BASED MEDICINE; HUMANS; MEDICAL MARIJUANA; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; STATE GOVERNMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84902589949     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.6175     Document Type: Note

References (10)

1. Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19(3):233-238. (Pubitemid 44309479)
2. Leweke FM, Piomelli D, Pahlisch F, et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012;2:e94.
3. Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35(3):764-774.
4. Kleber HD, DuPont RL. Physicians and medical marijuana. Am J Psychiatry. 2012;169(6):564-568.
5. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;24(10):1811-1820.
6. Cooper ZD, Comer SD, HaneyM. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology. 2013;38(10):1984-1992.
7. Castle DJ, Murray RM, D'Souza DC, eds. Marijuana and Madness. 2nd ed. New York, NY: Cambridge University Press; 2012.
8. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):2657-2664.
9. Verweij PE, Kerremans JJ, Voss A, Meis JF. Fungal contamination of tobacco and marijuana. JAMA. 2000;284(22):2875.
10. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328. (Pubitemid 47094993)